Unlocking the Future of MRI Imaging
AI-Powered Hyper-Magnification MRI Platform for Next-Level Precision Diagnostics
Existing MRI -> 7T equivalent
At NewMes, We leverage cutting-edge AI to upgrade conventional MRI equipment (1.5T, 3T) into ultra-high magnification MRI (7T equivalent), revolutionizing precision diagnostics and early disease detection.
See Beyond Limits
AlphaScan™
The world’s first AI solution transforming standard MRI systems into ultra-high magnification imaging platforms, delivering 7T-quality images without the need for expensive hardware upgrades.
Innovative Technology Solutions for Tomorrow
Innovative Technology Solutions for Tomorrow
AlphaScan™
Product Highlight (AlphaScan™)
AI-driven ultra-magnification for existing MRI
No hardware upgrade required
Early and accurate detection of neurological disorders, cancers, and more
Easy integration with hospital workflows
AlphaScan™ Version 1 (Demo)
Launching May 26, 2025 (Pilot Version)
AlphaScan™ Version 2 (Commercial Release)
Launching January 2, 2026 (Full Regulatory Approvals)
Technology
AlphaScan™: World’s First Integrated AI MRI Network
-
Integrated AI Workflow: Acquisition + Reconstruction unified into a single AI framework.
Zero-shot Self-Learning AI: Delivers ultra-magnified MRI images without pre-existing data.
MRI Simulator & Optimization: AI-driven simulation finds optimal scanning parameters.
Ultra-Magnification Capability: Equivalent to 7T MRI, up to cellular-level imaging for biopsies-free diagnostics in the future.
-
No additional hardware costs.
Applicable across all MRI brands and models.
Immediate, measurable clinical impact (early-stage detection of Alzheimer's, MS, cancers).
Product
AlphaScan™ Product Line
Expected Applications
Neurological diseases (e.g., Alzheimer’s, MS, Parkinson’s)
Early cancer detection (e.g., small tumor lesions, micro-metastasis)
Advanced pharmaceutical trials (precise biomarker monitoring)
About
our company
Who We Are
NewMes is a global deep-tech startup founded by world-class MRI, AI, and imaging physics experts. Our groundbreaking technology, AlphaScan™, leverages proprietary AI algorithms and novel MRI physics modeling to push the boundaries of conventional MRI, enabling ultra-high magnification imaging comparable to advanced 7T MRI—without hardware upgrades.
Our Mission
To solve humanity’s toughest healthcare challenges through advanced AI technologies, empowering precision medicine and enabling people to live healthier, better lives.
Our Vision
To become the global standard in AI-driven medical imaging solutions, starting with AlphaScan™, the world's first MRI hyper-magnification platform capable of ultra-precise diagnostics at cellular-level resolution.
Key Achievement
🏆 Global Recognition & Awards
1st Place, Global Medical LLM Competition by HuggingFace, Edinburgh NLP Lab & OpenLifeScienceAI (Jun 2024)
Recognized as Global #1 Medical LLM by Nature Reviews Bioengineering (Feb 2025)
CVPR Publication: MRI Zero-shot Reconstruction Technology (Jun 2025)
📈 Corporate & Investment Milestones
NewMes Inc. Founded (Jun 2024)
Seed Investment Successfully Secured (Oct 2024)
Certified as an Official Venture Enterprise (Dec 2024)
Corporate Research Institute Established (Feb 2025)
Selected for Deep Tech TIPS Fast Track by Ministry of SMEs and Startups (May 2025)
🤝 Strategic Global Partnerships
Leading MRI Manufacturer: Philips
Premier Medical Institutions: Samsung Medical Center, Severance Hospital
Top Research Institutions & Corporations: MILA, Google Canada
Global Presence
Headquarters : Seoul, South Korea
AI Research Lab : Montreal, Canada